Travere Therapeutics
TVTX
#4846
Rank
A$2.20 B
Marketcap
$24.81
Share price
-9.48%
Change (1 day)
133.50%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -$6.78

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.48. In 2022 the company made an earnings per share (EPS) of -$7.23 a decrease over its 2021 EPS that were of -$5.02.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.78-6.19%
2022-$7.2344.22%
2021-$5.02-10.09%
2020-$5.58-2.6%
2019-$5.7336.22%
2018-$4.2064.94%
2017-$2.5520.31%
2016-$2.12-135.46%
2015$5.98-175.68%
2014-$7.9098.75%
2013-$3.971746.15%
2012-$0.221.34%
2011-$0.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.66-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.45-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA